Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00525109 · ClinicalTrials.gov registry record
Elevated Serum HDL in Four Generations of a Nashville Family
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Terminated
- Registry status
- 3
- Enrollment target
NCT00525109: Clinical Trial study, sponsored by Vanderbilt University Medical Center.
NCT00525109 is a clinical trial that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00525109 was terminated before completion, sponsored by Vanderbilt University Medical Center.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the genetic basis of one family's hereditary hyper-HDL-emia using multiple modalities such as linkage analysis and gene array.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2004-06 |
| Est. Completion | 2006-06 |
Why NCT00525109 stopped before completion
NCT00525109 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT00525109 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00525109 about?
NCT00525109 is a clinical study titled "Elevated Serum HDL in Four Generations of a Nashville Family". The purpose of this study is to determine the genetic basis of one family's hereditary hyper-HDL-emia using multiple modalities such as linkage analysis and gene array.
What is the current status of trial NCT00525109?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2004-06. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00525109?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT00525109?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia